Jazz Pharmaceuticals PLC
NASDAQ:JAZZ

Watchlist Manager
Jazz Pharmaceuticals PLC Logo
Jazz Pharmaceuticals PLC
NASDAQ:JAZZ
Watchlist
Price: 125.06 USD -2.03%
Market Cap: 7.7B USD
Have any thoughts about
Jazz Pharmaceuticals PLC?
Write Note

Jazz Pharmaceuticals PLC
Operating Expenses

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Jazz Pharmaceuticals PLC
Operating Expenses Peer Comparison

Comparables:
PRGO
AVDL
G
GHRS
COPN
OVB

Competitive Operating Expenses Analysis
Latest Figures & CAGR of Competitors

Company Operating Expenses CAGR 3Y CAGR 5Y CAGR 10Y
Jazz Pharmaceuticals PLC
NASDAQ:JAZZ
Operating Expenses
-$2.9B
CAGR 3-Years
-10%
CAGR 5-Years
-17%
CAGR 10-Years
-14%
Perrigo Company PLC
NYSE:PRGO
Operating Expenses
-$1.3B
CAGR 3-Years
-18%
CAGR 5-Years
0%
CAGR 10-Years
-5%
Avadel Pharmaceuticals PLC
NASDAQ:AVDL
Operating Expenses
-$188.8m
CAGR 3-Years
-43%
CAGR 5-Years
-15%
CAGR 10-Years
-14%
G
GH Research PLC
NASDAQ:GHRS
Operating Expenses
-$41.2m
CAGR 3-Years
-351%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Cosmo Pharmaceuticals NV
SIX:COPN
Operating Expenses
-€53.6m
CAGR 3-Years
-20%
CAGR 5-Years
1%
CAGR 10-Years
-6%
Ovoca Bio PLC
LSE:OVB
Operating Expenses
-€4m
CAGR 3-Years
-5%
CAGR 5-Years
-11%
CAGR 10-Years
7%

See Also

What is Jazz Pharmaceuticals PLC's Operating Expenses?
Operating Expenses
-2.9B USD

Based on the financial report for Sep 30, 2024, Jazz Pharmaceuticals PLC's Operating Expenses amounts to -2.9B USD.

What is Jazz Pharmaceuticals PLC's Operating Expenses growth rate?
Operating Expenses CAGR 10Y
-14%

Over the last year, the Operating Expenses growth was 8%. The average annual Operating Expenses growth rates for Jazz Pharmaceuticals PLC have been -10% over the past three years , -17% over the past five years , and -14% over the past ten years .

Back to Top